Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
167.21
-1.27 (-0.75%)
At close: Aug 10, 2026, 4:00 PM EDT
168.82
+1.61 (0.96%)
Pre-market: Aug 11, 2026, 9:12 AM EDT
Guardant Health (GH) Revenue by Segment
| Date | Oncology | Biopharma and Data | Screening | Licensing and Other | Development Services | Precision Oncology Testing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | 798.41M | 222.66M | 153.70M | 8.34M | - | - |
| Mar 31, 2026 | 737.99M | 217.73M | 115.65M | 8.85M | - | - |
| Dec 31, 2025 | 683.60M | 210.13M | 79.73M | 8.56M | - | - |
| Sep 30, 2025 | 493.65M | 156.13M | 44.60M | 6.38M | 17.23M | 184.59M |
| Jun 30, 2025 | 309.24M | 101.40M | 20.49M | 4.43M | 28.10M | 365.19M |
| Mar 31, 2025 | 150.56M | 45.38M | 5.68M | 1.86M | 38.82M | 531.71M |
| Dec 31, 2024 | - | - | - | - | 51.08M | 687.94M |
| Sep 30, 2024 | - | - | - | - | 46.72M | 645.54M |
| Jun 30, 2024 | - | - | - | - | 45.45M | 598.36M |
| Mar 31, 2024 | - | - | - | - | 46.64M | 557.09M |
| Dec 31, 2023 | - | - | - | - | 49.70M | 514.25M |
| Sep 30, 2023 | - | - | - | - | 49.93M | 485.86M |
| Jun 30, 2023 | - | - | - | - | 55.67M | 454.49M |
| Mar 31, 2023 | - | - | - | - | 60.85M | 421.31M |
| Dec 31, 2022 | - | - | - | - | 57.49M | 392.05M |
| Sep 30, 2022 | - | - | - | - | 63.80M | 366.96M |